Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression.
Saved in:
| Title: | Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression. |
|---|---|
| Authors: | Kader T; Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Zethoven M; Peter MacCallum Cancer Centre, Melbourne, Australia., Mahale S; Peter MacCallum Cancer Centre, Melbourne, Australia., Saunders H; Peter MacCallum Cancer Centre, Melbourne, Australia., Tjoeka L; Peter MacCallum Cancer Centre, Melbourne, Australia., Lehmann R; Peter MacCallum Cancer Centre, Melbourne, Australia., Jayawardana MW; Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Pang JM; Peter MacCallum Cancer Centre, Melbourne, Australia., Lesche D; Peter MacCallum Cancer Centre, Melbourne, Australia., Rajan N; The Breast Service, The Royal Women's Hospital, Melbourne, Australia., Semple T; Peter MacCallum Cancer Centre, Melbourne, Australia., Lee JEA; Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Lupat R; Peter MacCallum Cancer Centre, Melbourne, Australia., Byrne DJ; Peter MacCallum Cancer Centre, Melbourne, Australia., Hughes S; Peter MacCallum Cancer Centre, Melbourne, Australia., Nguyen H; Peter MacCallum Cancer Centre, Melbourne, Australia., Lai S; Peter MacCallum Cancer Centre, Melbourne, Australia., Pechlivanis M; Peter MacCallum Cancer Centre, Melbourne, Australia., Craig O; Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Devereux L; Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., House E; Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia., Jayasinghe SI; Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia.; Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia., Kaufmann TL; Institute for Computational Cancer Biology (ICCB), Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; BIFOLD - Berlin Institute for the Foundations of Learning and Data, Berlin, Germany.; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Schwarz RF; Institute for Computational Cancer Biology (ICCB), Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; BIFOLD - Berlin Institute for the Foundations of Learning and Data, Berlin, Germany., Green AR; Nottingham Breast Cancer Research Centre, Academic Unit of Translational Medical Sciences, School of Medicine, University of Nottingham and Department of Histopathology, Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, UK., Miligy IM; Nottingham Breast Cancer Research Centre, Academic Unit of Translational Medical Sciences, School of Medicine, University of Nottingham and Department of Histopathology, Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, UK.; Pathology Department, Faculty of Medicine, Menoufia University, Shibin Al Kawm, Egypt., Cummings M; Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia., Lakhani S; Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.; Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia., Campbell IG; Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Rakha E; Nottingham Breast Cancer Research Centre, Academic Unit of Translational Medical Sciences, School of Medicine, University of Nottingham and Department of Histopathology, Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, UK.; Pathology Department, Hamad Medical Corporation, Doha, Qatar., Fox SB; Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Mann GB; Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; The Breast Service, The Royal Women's Hospital, Melbourne, Australia., Gorringe KL; Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia. |
| Source: | The Journal of pathology [J Pathol] 2026 Jan; Vol. 268 (1), pp. 1-12. Date of Electronic Publication: 2025 Oct 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
